More than 12,000 industry professionals, including 8,100 show attendees, participated in INTERPHEX 2013, a 20% increase over the 2012 show.
More than 12,000 industry professionals, including 8,100 show attendees, participated in INTERPHEX 2013, a 20% increase over the 2012 show, the show organizers report. The event, held April 23-25 at the Javits Center in New York, gave visitors the opportunity to connect with vendors and suppliers, while receiving the latest information on tools, methodologies and regulatory knowledge.
Congressman Bill Cassidy M.D.’s keynote presentation, “Policy Recommendations for Improving Patient Access to Drugs in Shortage”, offered potential improvements to the current reimbursement system to avoid future drug shortages. Another keynote session entitled “Reorganizing for the Future: Succeeding in the New Pharmaceutical Industry” featured Rajesh Nair, M.D., President of Indegene. Jim Miller, President, PharmSource Information Services, Inc., presented Recalibrating The Pharmaceutical Services Opportunity, in a third keynote, sponsored by Pharmaceutical Technology magazine.
PharmTech Publisher Mike Tracey (l) and Bob Stewart, Industry Vice President, INTERPHEX Events, meet on the floor of INTERPHEX 2013.Buyers had the opportunity to connect and network with new suppliers displaying the latest technologies. Exhibit Hall Technology Floor Tours offered critical insights followed by a walking tour to select vendors to showcase the latest technology and equipment on the Show Floor.
Russ Somma, PhD, INTERPHEX Advisory Board Member and Conference Speaker, stated, “Our event formula entailed attendees first be given real-time knowledge within the conference sessions that they could take to the Exhibit Hall to source specific organizational needs. We were confident that once the event ended our attendees could return to their firms and implement quickly what was gleaned at INTERPHEX. Learning, networking and implementation: a simple formula that can yield unprecedented success.”
“We’re thrilled with the signs of industry optimism that were evident at this year’s INTERPHEX. We saw an increased demand for product sourcing with a higher number of open industry projects fueling a surge in attendance, “ noted Bob Stewart, Industry Vice President, INTERPHEX Events. “We at INTERPHEX will continue to bring insightful and critical information to our future attendees, and we look forward to seeing all next year, March 18-20, 2014 at the Javits Center in New York City.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.